cancer_study_identifier: paad_iatlas_prince_2022
type_of_cancer: paad
name: Metastatic Pancreatic Adenocarcinoma (PRINCE Trial, Nat Med. 2022) - iAtlas Harmonized
pmid: 35662283
reference_genome: hg38
citation: Padron et al. Nat Med. 2022
description: Whole-exome sequencing and neoantigen landscape analysis of 93 metastatic pancreatic adenocarcinomas and their matched normals from a randomized phase 2 trial evaluating the efficacy of nivolumab and/or sotigalimab with gemcitabine/nab-paclitaxel (chemotherapy) as first-line therapy for metastatic pancreatic cancer. The reprocessing of raw sequencing data is coordinated by <a href="https://cri-iatlas.org/">CRI iAtlas</a>.
